Production of leukotriene B4 (LTB4) by human neutrophils (PMN) in response to different stimuli is increased after pretreatment with lipopolysaccharides (LPS). We have analyzed the steps in arachidonic acid (AA) metabolism affected by LPS by examining release of AA and its metabolites from [3HIAA prelabeled PMN. Pretreatment of PMN for 60 min with up to 1 yg/ml of LPS alone had no effect, but release of 13HIAA was stimulated up to fivefold during subsequent stimulation with a second agent. In the absence of LPS-binding protein (LBP), priming was maximal after pretreatment of PMN with 10 ng of LPS/ml for 60 min; in the presence of LBP maximal priming occurred within 45 min at 0.1 ng of LPS/ml and within 15 mi at 100 ng of LPS/ml. Treatment of PMN with 10 ng of LPS/ ml also increased uptake of opsonized zymosan by up to 60%. Phospholipids are the source of released 13HIAA. No release was observed from I'4CIoleic acid (OA)-labeled PMN suggesting that phospholipolysis may be specific for 13HIAA-labeled phospholipid pools. Cytosol from PMN primed with LPS contains two to three times the phospholipase A2 (PLA2) activity of control PMN, against 1-palmitoyl-12-14C1-arachidonoyl-phosphatidylcholine. This activity is Ca2+ dependent and dithiothreitol resistant. LPS priming is accompanied by reduced migration during SDS-PAGE of an 85-kD protein, identified as a cytosolic PLA2. The extent and kinetics of this effect of LPS on cPLA2 parallel the priming of 13HIAA release, both depending on LPS concentration either with or without LBP. These findings suggest that priming by LPS of AA metabolism by PMN includes phosphorylation of an AA-phospholipid-selective cytosolic PLA2 that is dissociated from activation until a second stimulus is applied. (J. Clin. Invest. 1994. 93:1583-1591 
Introduction
Infections with Gram-negative organisms and septic shock remain a major cause of morbidity and mortality of hospitalized patients ( I (2, 3) .
The PMN is a major target for the action of bacterial LPS and plays an essential role in host defense to bacterial infection. LPS in concentrations as low as 0.1 ng/ml has been shown to "prime" PMN for enhanced production of leukotriene B4 (LTB4) in response to both particulate (opsonized zymosan; OZ) and soluble (A23 187, PMA) stimuli (4) . LTB4 is a potent chemo-attractant ( 5 ) and promotes fluid extravasation into the interstitium by PMN-mediated increases in vascular permeability (6) . The initial step in eicosanoid production is the release of arachidonic acid from the sn-2 position of phospholipase (PL) . The enzyme(s) involved in hydrolysis have not yet been definitively identified. An 85-kD cytosolic phospholipase A2 (cPLA2) with preference for AA containing PL has been described in rabbit PMN and HL-60 cells (7, 8) and similar enzymes have been purified from macrophage-like cell lines (9-1 1). Several granule-associated PLA2 have also been characterized which have an uncertain role in AA metabolism ( 12, 13). PLC followed by diacylglycerol-lipase with or without monoacylglycerol-lipase digestion of PL is probably of limited significance in AA metabolism by PMN (14) . LTB4 produced by 5-lipoxygenase (5LO) is the major PMN metabolite ofreleased AA. Upregulation by LPS ofeither a lipolytic step and/or 5LO activity could account for the enhanced LTB4 production found after a second stimulus.
LPS triggers increased surface expression of CR1 and CR3 (15, 16) and enhanced phagocytosis ofopsonized bacteria ( 17) and yeast ( 18 ) . Thus, increased phagocytic activity might also contribute to increased AA metabolism (LTB4 production) triggered by a particulate stimulus.
In this report we show that priming of PMN by LPS results in preferential hydrolysis of AA containing phospholipids when a second stimulus is applied. LPS priming is both amplified and accelerated by the presence of LBP. LPS also increases phagocytosis of OZ by PMN, which might contribute to improved host defense, but does not account for the increase in AA release. Priming of PMN is accompanied by phosphorylation of an arachidonoyl-selective 85-kD cPLA2 and greater DTT-resistant, Ca2+-dependent, arachidonoyl-selective PLA2 activity in cytosolic fractions, suggesting that phosphorylation of this cPLA2 may contribute to the enhanced release of AA and production of LTB4 by primed PMN.
Methods
Materials. Special reagents used are as follows: sterile pyrogen-and, preservative-free heparin (porcine intestine), (Squibb-Marsam, Cherry Hill, NJ), Pyrogen-free dextran, mol wt range 200,000-300,000 (United States Biochemical Corp., Cleveland, OH), HBSS (GIBCO, Grand Island, NY), [3H]AA 60-100 Ci/mmol, L-a-lpalmitoyl- [2-14C ] arachidonoyl-phosphatidylcholine 40- Preparation of endotoxin. Highly purified protein-free LPS extracted from S. minnesota Re595 mutant was prepared as a stock solution (1 mg/ml) in sterile, pyrogen-free water and sonicated as previously described (4).
Neutrophil priming by LPS. 250 , 1 A of a neutrophil suspension (2.0 X 107/ml) in HBSS(-) with or without LPS was incubated in a shaking water bath at 37°C for 45-60 min in most experiments or for varied times as indicated (4, 21 Cytosolic PLA2 assays. PMN were pelleted and resuspended in cavitation buffer containing 50 mM Hepes pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, and an antiprotease cocktail of leupeptin 100 Mig/ml, pepstatin 100 ng/ml, aprotinin 100 ,g/ml, TPCK 100 jg/ml, PMSF 2 mM, benzamidine 100 jiM, iodoacetamide 1 mM, and chymostatin 100 jig/ml. The cell mixture was pressurized to 1,000 psi in a cell disruption bomb (Parr Instruments, Moline, IL) for 10 min and collected through the release valve. Cytosol was collected after centrifugation at 100,000 g for 30 min. Immunoprecipitation and immunoblot ofcPLA2. PMN cytosol was prepared as above and incubated overnight at 40C with mAb 1,1,1 raised against cPLA2 from U937 cells (20) . Protein A-sepharose was added for an additional 2 h, centrifuged, and washed three times followed by addition of SDS sample buffer for SDS-PAGE. Samples were electrophoresed on a SDS/7.5% polyacrylamide gel for 2 h longer than the time required for the solvent front to elute (27) . Western transfer to nitrocellulose was accomplished overnight at 40 V at 40C followed by immunoblot using polyclonal rabbit serum raised against cPLA2 from U937 cells (20) and the ECL detection system (Amersham Corp., Arlington Hts., IL). Granule-free membrane fractions were prepared as previously described (28) . release with further increases at higher LPS concentrations, reaching a maximum at 10 ng/ml (Fig. 1 A) . The priming effect of LPS was evident over a broad range of OZ concentrations (not shown). Maximal priming effects of LPS on both
Results

Pretreatment of PMN with LPS increases
[3H ]AA release and LTB4 production required [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] min of preincubation of PMN with LPS before addition of OZ (Fig. 1  B) . In these (and all subsequent) assays, albumin ( (3, 15, 29) , the effect of LBP on LPS priming of PMN release of [3H ]AA and production ofLTB4 was examined. Addition ofLBP to the cell suspension before LPS, elicited a maximal priming response at levels of LPS as low as 0.1 ng/ml, i.e., a 100-1000-fold increase in the sensitivity ofthe PMN to LPS priming (Fig. 2) . LBP alone did not prime PMN. With increasing LPS concentrations, LBP progressively reduced the time of preincubation needed to achieve maximal stimulation of [3H ]AA release after addition of OZ (from 60 min without LBP to . 15 min with LBP, 0.75 jig/ml and 100 ng LPS/ml; Fig. 2 ). The transient nature of LPS-priming was observed at all doses of LPS (with and without LBP) (Figs. 1 and 2) . The effects of LBP on LPS-priming of LTB4 production parallel those on [3H]AA release (not shown). LPS priming (with and without LBP) was completely inhibited when a neutralizing monoclonal antibody to CDl4 was added before LPS but not when this antibody was added 5 min after LPS (with and without LBP) (Fig. 3) . Unrelated, isotype-matched control monoclonal antibody had no inhibitory effect. Mabs altered the effect of OZ on PMN and PMA was therefore used as the second stimulant for these studies. mmn at 370C as in Fig. 1 . Column 1, LPS = 0; 2, LPS = 0.1 ng/ml; 3, LPS = 1.0 ng/ml; 4, LPS = 10 ng/ml; and 5-9, LPS = 100 ng/ml.
Anti-CD14 mAbs (MY4, 2.5 ysg/ml) were added to PMN before LPS (6) or 5 mmn after LPS (7 than untreated PMN over a wide range of OZ concentrations (Fig. 4) . Uptake of OZ both in the presence and absence of LPS was complete within 5 mmn (not shown). Uptake of unopsonized zymosan is < 25% of OZ and was not increased by pretreatment with LPS (not shown). That increased uptake represented ingestion rather than adherence was verified as described in Methods by fluorescent microscopy of LPS-pretreated and control PMN after incubation with FITC-labeled OZ. In contrast to the requirement for preincubation with LPS forthe priming of[3H]AA and LTB4 release, no preincubation was necessary for the LPS effect on uptake of OZ, nor was stimulation diminished by longer preincubation with LPS (Fig.  4 B) . The differences in the magnitude (Fig. 4 , A and C) and time dependence of these two effects of LPS suggest that priming of AA metabolism includes effects on the cellular AA metabolic machinery that are distinct from effects on phagocytosis.
Moreover, LPS priming of [3H]IAA release was also observed with non-phagocytic (soluble) stimuli including the Ca2+ ionophore A23 187 and PMA (Table I) (27) . This "gel-shift" is linked to phosphorylation and reversed by phosphatase treatment (27) . Fig. 5 (Table III) . Both cPLA2 species were recovered only from cytosolic fractions ( 100,000-g supernatant) when sedimentation ofPMN cavitates was carried out in 1 mM EGTA ( Fig. 6; lanes 1, 2, 5 , and 6). By contrast, both species were lost from the cytosolic fractions and recovered in purified PMN granule-free membrane fractions when these two fractions were mixed and reseparated by centrifugation in the presence of 10 ,M free Ca2+ (lanes 3, 4, 7, and 8) (20, 34) . At 100 nM free Ca2" essentially no cPLA2 associates with the membranes and at 300 nM free Ca2' 80-90% is membrane associated (not shown) similar to what has been previously described with U937 cell derived cPLA2 (20) . Effect ofstaurosporine on PMA-mediated cPLA2 phosphorylation and activation ofAA (with and without LPSpriming) in PMN. (27) . These investigators have prothis cell in vivo in the defense posed that while phosphorylation of cPLA2 is necessary for ading Gram-negative bacteria maximal activation, hydrolytic activity is expressed only if the ng the many PMN functions enzyme associates with its substrate in an additional, Ca2+-deto LPS are generation ofreacpendent, step (35) . As in that study, we have shown that phos-LTB4 (4), expression on the phorylation of the cPLA2 in PMN is associated with a two-to iponents of complement and threefold increase in calcium-requiring hydrolytic activity of nced phagocytosis of bacteria cytosolic fractions (containing all recovered cPLA2) toward 1-ssed on the further analysis of palmitoyl-[ '4C]arachidonoyl PC (Table III) . Because LPS r the generation of the potent treatment ofPMN causes little (40) or no (4) increase in Cai2+, we speculate that activation ofAA release awaits a second stim-PMN with LPS alone causes ulus (e.g., OZ, A23187) that triggers increased Ca,2+ (4) and,
[3H]AA from esterified lipid hence, Ca2+-dependent translocation of the cPLA2 to a memAf LTB4 or LTB4 metabolites brane (substrate) site where hydrolysis occurs. Such a scheme l in esterified lipid pools of is consistent with the inability of FMLP to activate [3H]AA lar sources differs from that of release (with or without LPS priming) apparently because the kA (36, 37) , no release of AA increase in Ca,24 triggered by FMLP is insufficient to meet the N has been described without requirements for cPLA2 activation (41, 42) .
ation of radiolabeled AA pools However, this scheme does not readily explain the potent our investigations by gas chroactivating effects of PMA in PMN (Table I) (Fig. 1). cPLA2 but no change in intracellular calcium; and priming but e requirements for formation little or no activation ofAA release (27 (49) (50) (51) and activation of protein tyrosine phosphorylation (52) . How LBP accelerates LPS priming is not known but apparently involves increasing the rate of post-CD14 events. How LPS almost immediately increases cellular uptake of OZ is also unknown but suggests a very different mechanism of action. Finally, how the priming effects of LPS on AA metabolism are reversed (see Figs. 1 and  2 ) is unknown but reversal is apparently distinct from the phosphorylation event(s) that cause the gel shift and increased cell-free activity of cPLA2. With tumor necrosis factor as the priming agent (53) , the transient nature of priming of PMN AA metabolism is also observed with effects on cPLA2 phosphorylation (gel shift) similar to LPS-priming (unpublished observations) suggesting that reversible priming is an inherent feature of complex mechanisms regulating AA metabolism (cPLA2) activity in PMN.
